Pourya Gholizadeh
Overview
Explore the profile of Pourya Gholizadeh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
998
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kadkhoda H, Gholizadeh P, Ghotaslou R, Nabizadeh E, Pirzadeh T, Rezaee M, et al.
Microb Pathog
. 2024 Nov;
199():107151.
PMID: 39615707
Background And Objectives: The bacterial adaptive immune system known as CRISPR-Cas (clustered regularly interspersed short palindromic repeats-CRISPR-associated protein) is engaged in defense against various mobile genetic elements (MGEs) such as...
2.
Gholizadeh P, Faghfouri A, Furneri P, Faghfuri E
Front Pharmacol
. 2024 Oct;
15:1497524.
PMID: 39444604
No abstract available.
3.
Kadkhoda H, Gholizadeh P, Kafil H, Ghotaslou R, Pirzadeh T, Rezaee M, et al.
Heliyon
. 2024 Aug;
10(14):e34692.
PMID: 39149034
The emergence and development of antibiotic resistance in bacteria is a serious threat to global public health. Antibiotic resistance genes (ARGs) are often located on mobile genetic elements (MGEs). They...
4.
Panahizadeh R, Vatankhah M, Safari A, Danesh H, Nazmi N, Gholizadeh P, et al.
Cancer Cell Int
. 2024 Jul;
24(1):234.
PMID: 38970040
MicroRNAs (miRNAs), as a class of nonprotein-coding RNAs, post-transcriptionally regulate the expression of target genes by base pairing to 3'-untranslated regions (3'-UTRs). Nuclear factor E2-related factor 2 (Nrf2) has been...
5.
Kadkhoda H, Gholizadeh P, Ghotaslou R, Pirzadeh T, Rezaee M, Nabizadeh E, et al.
BMC Infect Dis
. 2024 Jun;
24(1):554.
PMID: 38831286
Background And Objective(s): CRISPR-Cas is a prokaryotic adaptive immune system that protects bacteria and archaea against mobile genetic elements (MGEs) such as bacteriophages plasmids, and transposons. In this study, we...
6.
Kashefieh M, Zeighami H, Kafil H, Gholizadeh P, Sadeghi J, Soroush Barhaghi M, et al.
Mol Biol Rep
. 2024 Mar;
51(1):416.
PMID: 38478145
Introduction: Klebsiella pneumoniae is an opportunistic pathogen which is an important cause of hospital-acquired and antibiotic resistance infections. Therefore, this study aimed to determine the frequency of resistance to antibiotics,...
7.
Faghfuri E, Gholizadeh P
Biomed Pharmacother
. 2024 Mar;
173:116416.
PMID: 38471272
Colorectal cancer (CRC) is the second most cancer-related death worldwide. In recent years, probiotics have been used to reduce the potential risks of CRC and tumors with various mechanisms. Different...
8.
Anaraki K, Zahed Z, Javid R, Shafiei S, Beiranvandi F, Ghasemi Kahrizsangi N, et al.
Vascul Pharmacol
. 2024 Feb;
154:107283.
PMID: 38340884
Aortic valve stenosis is the most common type of heart valve disease in the United States and Europe and calcific aortic stenosis (AS) affects 2-7% of people aged 65 years...
9.
Kashi P, Pakdel F, Soroush Barhaghi M, Rezaee M, Taghizadeh S, Sadeghi J, et al.
Egypt J Med Hum Genet
. 2023 Jul;
24(1):3.
PMID: 37519898
Background: Tuberculosis (TB) is considered one of the most infectious diseases in the world. In this study, we intended to examine the epidemiology of tuberculosis by MIRU-VNTR to define the...
10.
Nezhad-Mokhtari P, Kazeminava F, Abdollahi B, Gholizadeh P, Heydari A, Elmi F, et al.
Int J Biol Macromol
. 2023 Jul;
247:125718.
PMID: 37419259
Recently, developing antibacterial wound dressings based on biomaterials display good biocompatibility and the potential to accelerate wound healing. For this aim, we prepared eco-friendly and biodegradable nanofibers (NFs) based on...